HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-DEC-10 3PTG TITLE DESIGN AND SYNTHESIS OF A NOVEL, ORALLY EFFICACIOUS TRI-SUBSTITUTED TITLE 2 THIOPHENE BASED JNK INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 40-401; COMPND 5 SYNONYM: MAP KINASE 10, MAPK 10, MAP KINASE P49 3F12, STRESS- COMPND 6 ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL KINASE 3; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: C-JUN-AMINO-TERMINAL KINASE-INTERACTING PROTEIN 1; COMPND 11 CHAIN: J; COMPND 12 FRAGMENT: UNP RESIDUES 157-167; COMPND 13 SYNONYM: JIP-1, JNK-INTERACTING PROTEIN 1, ISLET-BRAIN 1, IB-1, JNK COMPND 14 MAP KINASE SCAFFOLD PROTEIN 1, MITOGEN-ACTIVATED PROTEIN KINASE 8- COMPND 15 INTERACTING PROTEIN 1; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK10, JNK3, JNK3A, PRKM10; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS JNK INHIBITOR, THIOPHENE, NEURODEGENERATION, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.BOWERS,A.P.TRUONG,J.NEITZ,M.NEITZEL,G.D.PROBST,R.K.HOM,A.W.KONRADI, AUTHOR 2 H.L.SHAM,G.TOTH,H.PAN,N.YAO,D.R.ARTIS,E.F.BRIGHAM,K.P.QUINN,J.SAUER, AUTHOR 3 K.POWELL,L.RUSLIM,F.BARD,T.A.YEDNOCK,I.GRISWOLD-PRENNER REVDAT 2 23-MAR-11 3PTG 1 JRNL REVDAT 1 02-MAR-11 3PTG 0 JRNL AUTH S.BOWERS,A.P.TRUONG,R.J.NEITZ,M.NEITZEL,G.D.PROBST,R.K.HOM, JRNL AUTH 2 B.PETERSON,R.A.GALEMMO,A.W.KONRADI,H.L.SHAM,G.TOTH,H.PAN, JRNL AUTH 3 N.YAO,D.R.ARTIS,E.F.BRIGHAM,K.P.QUINN,J.M.SAUER,K.POWELL, JRNL AUTH 4 L.RUSLIM,Z.REN,F.BARD,T.A.YEDNOCK,I.GRISWOLD-PRENNER JRNL TITL DESIGN AND SYNTHESIS OF A NOVEL, ORALLY ACTIVE, BRAIN JRNL TITL 2 PENETRANT, TRI-SUBSTITUTED THIOPHENE BASED JNK INHIBITOR. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 1838 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21316234 JRNL DOI 10.1016/J.BMCL.2011.01.046 REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 13169 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.247 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.316 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 701 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.43 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 993 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.24 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.4520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2841 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.12000 REMARK 3 B22 (A**2) : -0.61000 REMARK 3 B33 (A**2) : -0.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.382 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.284 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.196 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2934 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3973 ; 2.025 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 346 ; 8.045 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 135 ;34.717 ;24.296 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 527 ;20.881 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;17.510 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 435 ; 0.126 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2211 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1405 ; 0.253 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1949 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 104 ; 0.193 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 37 ; 0.243 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.250 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1812 ; 0.960 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2854 ; 1.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1289 ; 1.943 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1119 ; 2.950 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3PTG COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-10. REMARK 100 THE RCSB ID CODE IS RCSB062792. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9788 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13169 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.430 REMARK 200 RESOLUTION RANGE LOW (A) : 57.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3000, 0.1 M SODIUM CITRATE, 15% REMARK 280 GLYCEROL, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.88600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.72500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.21700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.72500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.88600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.21700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ASP A 45 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 SER A 217 REMARK 465 PHE A 218 REMARK 465 MET A 219 REMARK 465 MET A 220 REMARK 465 THR A 221 REMARK 465 PRO A 222 REMARK 465 TYR A 223 REMARK 465 VAL A 224 REMARK 465 ASP A 321 REMARK 465 SER A 322 REMARK 465 GLU A 323 REMARK 465 ARG J 153 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 326 CG CD CE NZ REMARK 470 LEU A 327 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 52 O SER A 56 1.93 REMARK 500 OH TYR A 229 OE1 GLU A 255 2.16 REMARK 500 O LEU A 206 O HOH A 7 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 153 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 LEU A 236 CA - CB - CG ANGL. DEV. = 14.1 DEGREES REMARK 500 LYS A 328 N - CA - C ANGL. DEV. = -16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 52 -71.75 -58.57 REMARK 500 VAL A 53 70.00 68.16 REMARK 500 GLN A 140 -46.84 -142.82 REMARK 500 MET A 159 -157.58 -69.09 REMARK 500 ARG A 188 -16.55 67.19 REMARK 500 LEU A 206 -95.65 -76.50 REMARK 500 ASP A 207 -153.00 -85.65 REMARK 500 PHE A 208 83.60 -174.62 REMARK 500 THR A 226 -0.43 167.39 REMARK 500 LYS A 241 -152.38 -132.55 REMARK 500 ASN A 243 3.28 -69.57 REMARK 500 PRO A 264 -160.53 -62.50 REMARK 500 ARG A 266 86.29 62.20 REMARK 500 ASP A 267 139.74 62.66 REMARK 500 PRO A 282 176.52 -56.73 REMARK 500 PRO A 292 98.80 -54.83 REMARK 500 THR A 293 -54.98 155.38 REMARK 500 THR A 308 155.84 78.17 REMARK 500 SER A 316 -17.51 -49.00 REMARK 500 PRO A 319 -24.24 -33.63 REMARK 500 ASN A 325 17.38 54.64 REMARK 500 LYS A 326 79.06 173.63 REMARK 500 LEU A 327 -141.19 20.82 REMARK 500 LYS A 328 -57.20 154.72 REMARK 500 ALA A 370 111.16 -38.87 REMARK 500 ASP A 377 94.39 -57.76 REMARK 500 LYS A 378 -45.46 -27.45 REMARK 500 LEU A 380 121.60 -25.35 REMARK 500 ASP A 381 -17.27 -177.89 REMARK 500 GLU A 382 124.75 65.27 REMARK 500 ARG A 383 118.86 89.13 REMARK 500 VAL A 398 37.98 -86.81 REMARK 500 MET A 399 20.02 175.10 REMARK 500 ASN A 400 33.88 -68.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 265 ARG A 266 37.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 GLU A 52 24.1 L L OUTSIDE RANGE REMARK 500 ILE A 77 23.9 L L OUTSIDE RANGE REMARK 500 LEU A 327 23.2 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 932 A 1 DBREF 3PTG A 40 401 UNP P53779 MK10_HUMAN 40 401 DBREF 3PTG J 153 163 UNP Q9UQF2 JIP1_HUMAN 157 167 SEQADV 3PTG ALA A 39 UNP P53779 EXPRESSION TAG SEQRES 1 A 363 ALA SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL SEQRES 2 A 363 GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 363 GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 363 VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN VAL SEQRES 5 A 363 ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 363 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS SEQRES 7 A 363 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 A 363 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 363 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 363 VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 363 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 363 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 363 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 363 PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET SEQRES 15 A 363 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 363 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 363 TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG HIS SEQRES 18 A 363 LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN TRP SEQRES 19 A 363 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU SEQRES 20 A 363 PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 A 363 GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO LYS SEQRES 22 A 363 LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU HIS SEQRES 23 A 363 ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 363 LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER VAL SEQRES 25 A 363 ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR SEQRES 26 A 363 ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 A 363 ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU SEQRES 28 A 363 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER SEQRES 1 J 11 ARG PRO LYS ARG PRO THR THR LEU ASN LEU PHE HET 932 A 1 26 HETNAM 932 N-[4-METHYL-3-(1H-1,2,4-TRIAZOL-5-YL)THIOPHEN-2-YL]-2- HETNAM 2 932 (2-OXO-3,4-DIHYDROQUINOLIN-1(2H)-YL)ACETAMIDE FORMUL 3 932 C18 H17 N5 O2 S FORMUL 4 HOH *28(H2 O) HELIX 1 1 ASN A 101 LYS A 116 1 16 HELIX 2 2 LEU A 153 MET A 159 1 7 HELIX 3 3 ASP A 162 ALA A 183 1 22 HELIX 4 4 LYS A 191 SER A 193 5 3 HELIX 5 5 THR A 226 ARG A 230 5 5 HELIX 6 6 ALA A 231 LEU A 236 1 6 HELIX 7 7 ASN A 243 HIS A 259 1 17 HELIX 8 8 ASP A 267 GLY A 280 1 14 HELIX 9 9 CYS A 283 LYS A 289 1 7 HELIX 10 10 THR A 293 ASN A 300 1 8 HELIX 11 11 THR A 308 PHE A 313 1 6 HELIX 12 12 PRO A 314 PHE A 318 5 5 HELIX 13 13 LYS A 328 LEU A 340 1 13 HELIX 14 14 ASP A 343 ARG A 347 5 5 HELIX 15 15 SER A 349 HIS A 356 1 8 HELIX 16 16 HIS A 356 VAL A 361 1 6 HELIX 17 17 ASP A 364 GLU A 369 1 6 HELIX 18 18 THR A 386 VAL A 398 1 13 SHEET 1 A 2 PHE A 48 VAL A 51 0 SHEET 2 A 2 PHE A 58 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 B 5 TYR A 64 GLY A 71 0 SHEET 2 B 5 GLY A 76 ASP A 83 -1 O TYR A 82 N GLN A 65 SHEET 3 B 5 ASN A 89 LEU A 95 -1 O LYS A 94 N ILE A 77 SHEET 4 B 5 TYR A 143 GLU A 147 -1 O LEU A 144 N LYS A 93 SHEET 5 B 5 LEU A 126 PHE A 130 -1 N LEU A 127 O VAL A 145 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 CISPEP 1 PHE A 208 GLY A 209 0 -2.10 CISPEP 2 GLY A 209 LEU A 210 0 22.84 CISPEP 3 LEU A 210 ALA A 211 0 1.47 CISPEP 4 HIS A 324 ASN A 325 0 17.82 CISPEP 5 LYS A 326 LEU A 327 0 15.33 CISPEP 6 LEU A 327 LYS A 328 0 25.95 CISPEP 7 GLN A 379 LEU A 380 0 3.72 CISPEP 8 ASP A 381 GLU A 382 0 13.01 SITE 1 AC1 11 ILE A 70 VAL A 78 ALA A 91 MET A 146 SITE 2 AC1 11 GLU A 147 MET A 149 ASP A 150 ALA A 151 SITE 3 AC1 11 ASN A 152 VAL A 196 HOH A 405 CRYST1 59.772 80.434 83.450 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016730 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012433 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011983 0.00000 MASTER 393 0 1 18 10 0 3 6 0 0 0 29 END